Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3EY4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,337
Award facts
- Contract value 100% obligated
- $16,336.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,336.74 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on December 18, 2025, with a completion date of December 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial $999,999,999.00 value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, supplies an extensive range of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent IDC enables the company to fulfill diverse pharmaceutical needs across multiple therapeutic domains through flexible delivery orders. This specific award for Ondansetron—an antiemetic medication commonly used in military and veteran healthcare settings—exemplifies the vendor's ongoing role as a prime pharmaceutical supplier within DLA's medical supply chain, particularly as the agency develops next-generation Pharmaceutical Prime Vendor Global Program contracts planned for multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26F3EY4?
SPE2DR26F3EY4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F3EY4 worth?
The government has obligated $16,337 on SPE2DR26F3EY4.
Is contract SPE2DR26F3EY4 an order under another contract?
Yes. SPE2DR26F3EY4 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3EY4 competed?
The extent of competition for SPE2DR26F3EY4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award